Drug Eluting Balloon Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Drug Eluting Balloon Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Drug eluting balloons are angioplasty balloons that are coated with an anti-proliferative drug, which is eluted in vessel walls during the inflation of balloon, usually at nominal pressure with a specific minimal inflation time. The active substance coated on the drug eluting balloon should be lipophilic in nature to have a high absorption rate through the vessel wall. Mostly paclitaxel is used as active ingredient due to its high pharmacokinetic transfer rate into the vessel wall and it is actively used in drug eluting balloons in the U.S. market and has been already approved for use in Europe.
Market Dynamics
Increasing prevalence of coronary artery diseases is a major factor driving drug eluting balloon market growth. According to American College of Cardiology, June 2021, around 17.92 million cardiovascular deaths were registered in 2015 worldwide. Moreover, key players in the market are focused on adopting acquisition strategies in order to gain access to innovative products and expand their product offerings in the potential markets. For instance, in April 2010, Medtronic acquired Invatec and affiliated companies. Invatec launched 4 new drug eluting balloons in Europe in 2009 including In.Pact Amphirion, In.Pact Admiral, In.Pact Pacific, and In.Pact Falcon. Medtronic is focused on enhancing its international presence by expanding treatment option for patients with cardiovascular disease.
Key features of the study:
This report provides in-depth analysis of the drug eluting balloon market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global drug eluting balloon market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global drug eluting balloon market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the drug eluting balloon market

Detailed Segmentation:
Global Drug Eluting Balloon Market, By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
Global Drug Eluting Balloon Market, By End User:
Hospitals
CATH Laboratories
Ambulatory Surgical Centers
Others
Global Drug Eluting Balloon Market, By Geography:
North America
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
U.S.
Canada
Latin America
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By End User:
Hospitals
CATH Laboratories
Ambulatory Surgery Centers
Others
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Medtronic *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Becton, Dickinson and Company
Boston Scientific Corporation
Cook Medical
B. Braun Melsungen AG
Koninklijke Philips N.V.
Opto Circuits (India) Limited
Terumo Corporation
Surmodics, Inc.
Biotronik
“*” marked represents similar segmentation in other categories in the respective section.